Did autologous cell therapy improve healing rates for diabetic foot ulcers?
Diabetic foot ulcers are a serious complication of diabetes that often do not heal with traditional treatments. Research shows that using a patient's own cells, known as autologous cell therapy, can significantly improve healing outcomes. A major review found that this therapy led to higher complete healing rates and faster reduction in ulcer size compared to control groups 3.
What the research says
A systematic review and meta-analysis of 26 randomized controlled trials involving over 2,200 patients found that autologous cell therapy resulted in a significantly higher rate of complete healing than the control group 3. The therapy also led to a greater reduction in the size of the ulcer area 3. Another analysis of bone marrow-derived cells showed that this approach significantly improved healing rates and reduced the risk of amputation 7.
Specific types of autologous cells have shown promise. One study evaluated adipose-derived stem cells injected after minor amputations and found a 69% healing probability at six months 5. Another trial tested a 'spray-on' skin method using autologous skin cells, which aims to shorten healing time and reduce costs 6. These findings suggest that different sources of a patient's own cells can be effective in treating these difficult wounds.
What to ask your doctor
- Is autologous cell therapy an appropriate option for my specific type of diabetic foot ulcer?
- What are the potential risks or side effects of using my own cells for wound healing?
- How much does autologous cell therapy cost compared to standard treatments?
- What is the expected healing timeline if I choose this therapy versus standard care?
This question is drawn from common patient questions about Diabetes & Endocrinology and answered using cited medical research. We do not provide individualized advice.